CYH
Income statement / Annual
Last year (2025), Community Health Systems, Inc.'s total revenue was $12.49 B,
a decrease of 1.18% from the previous year.
In 2025, Community Health Systems, Inc.'s net income was $509.00 M.
See Community Health Systems, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$12.49 B |
$12.63 B |
$12.49 B |
$12.21 B |
$12.37 B |
$11.79 B |
$13.21 B |
$14.16 B |
$15.35 B |
$18.44 B |
| Cost of Revenue |
$11.40 B
|
$7.36 B
|
$7.41 B
|
$7.31 B
|
$7.28 B
|
$7.37 B
|
$8.10 B
|
$8.74 B
|
$10.05 B
|
$11.64 B
|
| Gross Profit |
$1.08 B
|
$5.27 B
|
$5.08 B
|
$4.91 B
|
$5.08 B
|
$4.42 B
|
$5.11 B
|
$5.42 B
|
$5.31 B
|
$6.80 B
|
| Gross Profit Ratio |
0.09
|
0.42
|
0.41
|
0.4
|
0.41
|
0.37
|
0.39
|
0.38
|
0.35
|
0.37
|
| Research and Development Expenses |
$0.00
|
$0.00
|
$80.00 M
|
$85.00 M
|
$108.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$0.00
|
$299.00 M
|
$319.00 M
|
$317.00 M
|
$308.00 M
|
$327.00 M
|
$321.00 M
|
$337.00 M
|
$394.00 M
|
$450.00 M
|
| Other Expenses |
$11.00 B
|
$4.43 B
|
$3.73 B
|
$3.68 B
|
$3.27 B
|
$2.96 B
|
$4.14 B
|
$4.87 B
|
$6.79 B
|
$7.21 B
|
| Operating Expenses |
$11.00 B
|
$4.73 B
|
$4.13 B
|
$4.09 B
|
$3.68 B
|
$3.29 B
|
$4.46 B
|
$5.21 B
|
$7.18 B
|
$7.66 B
|
| Cost And Expenses |
$22.40 B
|
$12.09 B
|
$11.53 B
|
$11.39 B
|
$10.97 B
|
$10.66 B
|
$12.56 B
|
$13.95 B
|
$17.23 B
|
$19.30 B
|
| Interest Income |
$0.00
|
$3.00 M
|
$2.00 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$11.00 M
|
$0.00
|
| Interest Expense |
$870.00 M
|
$863.00 M
|
$832.00 M
|
$858.00 M
|
$885.00 M
|
$1.03 B
|
$1.04 B
|
$976.00 M
|
$942.00 M
|
$962.00 M
|
| Depreciation & Amortization |
$426.00 M
|
$406.00 M
|
$425.00 M
|
$449.00 M
|
$432.00 M
|
$435.00 M
|
$487.00 M
|
$560.00 M
|
$683.00 M
|
$899.00 M
|
| EBITDA |
$2.02 B |
$1.25 B |
$1.30 B |
$1.17 B |
$1.71 B |
$1.01 B |
$1.39 B |
$1.45 B |
$899.00 M |
$1.98 B |
| EBITDA Ratio |
0.16
|
0.1
|
0.1
|
0.1
|
0.14
|
0.09
|
0.11
|
0.1
|
0.06
|
0.11
|
| Operating Income Ratio |
-0.79
|
0.04
|
0.08
|
0.07
|
0.11
|
0.1
|
0.05
|
0.01
|
-0.12
|
-0.05
|
| Total Other Income/Expenses Net |
$10.64 B
|
-$825.00 M
|
-$750.00 M
|
-$472.00 M
|
-$903.00 M
|
-$704.00 M
|
$0.00
|
-$923.00 M
|
-$955.00 M
|
-$855.00 M
|
| Income Before Tax |
$724.00 M
|
-$283.00 M
|
$207.00 M
|
$349.00 M
|
$499.00 M
|
$422.00 M
|
-$430.00 M
|
-$715.00 M
|
-$2.83 B
|
-$1.72 B
|
| Income Before Tax Ratio |
0.06
|
-0.02
|
0.02
|
0.03
|
0.04
|
0.04
|
-0.03
|
-0.05
|
-0.18
|
-0.09
|
| Income Tax Expense |
$48.00 M
|
$79.00 M
|
$191.00 M
|
$170.00 M
|
$131.00 M
|
-$185.00 M
|
$160.00 M
|
-$11.00 M
|
-$449.00 M
|
-$104.00 M
|
| Net Income |
$509.00 M
|
-$516.00 M
|
-$133.00 M
|
$46.00 M
|
$230.00 M
|
$511.00 M
|
-$590.00 M
|
-$788.00 M
|
-$2.46 B
|
-$1.72 B
|
| Net Income Ratio |
0.04
|
-0.04
|
-0.01
|
0
|
0.02
|
0.04
|
-0.04
|
-0.06
|
-0.16
|
-0.09
|
| EPS |
3.8 |
-3.9 |
-1.02 |
0.36 |
1.82 |
4.42 |
-5.19 |
-6.99 |
-22 |
-15.55 |
| EPS Diluted |
3.77 |
-3.9 |
-1.02 |
0.35 |
1.76 |
4.38 |
-5.19 |
-6.99 |
-22 |
-15.54 |
| Weighted Average Shares Out |
$134.00 M
|
$132.10 M
|
$130.39 M
|
$128.81 M
|
$126.75 M
|
$115.49 M
|
$113.74 M
|
$112.73 M
|
$111.77 M
|
$110.71 M
|
| Weighted Average Shares Out Diluted |
$135.00 M
|
$132.10 M
|
$130.45 M
|
$130.06 M
|
$130.60 M
|
$116.54 M
|
$113.74 M
|
$112.73 M
|
$111.77 M
|
$110.73 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
